Dr. Humayun has dedicated much of his career to both clinical and scientific research in the fields of ophthalmology and bioengineering, becoming both a biomedical engineer and professor of ophthalmology. Dr. Humayun led a talented and diverse team of interdisciplinary researchers to the lab's ultimate goal of creating the world’s first artificial retina. To do this, he assembled a team of world experts with a wide and interdisciplinary range of proficiencies, including biomedical engineering, computer science, medicine, chemistry, biology and business. Since the clinical trials in 2007 and subsequent approval by the FDA in 2013, the Argus II retinal implant represents the culmination of a visual restoration strategy that offers an unprecedented new degree of sight to those with complete retinal blindness. Dr. Humayun was elected in to the prestigious National Academy of Medicine (NAM) and to National Academy of Engineering (NAE) for his pioneering work to restore sight to those with retinal blindness. Dr. Humayun has received several research awards which including the 2005 Innovator of the Year award, and has over 200 publications and more than 100 patents and applications. He was also featured as one of the top 10 inventors in Time Magazine in 2013, voted as one of the Best Doctors in America for three years, and was ranked as one of the top 1% of Doctors by U.S. News & World Report. In 2016, Dr. Humayun received the National Medal of Technology and Innovation from President Barack Obama for his innovative work and development of the Argus II retinal implant.